» Articles » PMID: 25551456

Subfamily-specific Adaptations in the Structures of Two Penicillin-binding Proteins from Mycobacterium Tuberculosis

Overview
Journal PLoS One
Date 2015 Jan 1
PMID 25551456
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Beta-lactam antibiotics target penicillin-binding proteins including several enzyme classes essential for bacterial cell-wall homeostasis. To better understand the functional and inhibitor-binding specificities of penicillin-binding proteins from the pathogen, Mycobacterium tuberculosis, we carried out structural and phylogenetic analysis of two predicted D,D-carboxypeptidases, Rv2911 and Rv3330. Optimization of Rv2911 for crystallization using directed evolution and the GFP folding reporter method yielded a soluble quadruple mutant. Structures of optimized Rv2911 bound to phenylmethylsulfonyl fluoride and Rv3330 bound to meropenem show that, in contrast to the nonspecific inhibitor, meropenem forms an extended interaction with the enzyme along a conserved surface. Phylogenetic analysis shows that Rv2911 and Rv3330 belong to different clades that emerged in Actinobacteria and are not represented in model organisms such as Escherichia coli and Bacillus subtilis. Clade-specific adaptations allow these enzymes to fulfill distinct physiological roles despite strict conservation of core catalytic residues. The characteristic differences include potential protein-protein interaction surfaces and specificity-determining residues surrounding the catalytic site. Overall, these structural insights lay the groundwork to develop improved beta-lactam therapeutics for tuberculosis.

Citing Articles

The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study.

Hunt A, Khan I, Wu A, Makohon-Moore S, Hood B, Conrads K Clin Exp Metastasis. 2023; 41(3):229-249.

PMID: 37917186 DOI: 10.1007/s10585-023-10233-7.


Crystal Structure of Phosphoserine BlaC from Inactivated by Bis(Benzoyl) Phosphate.

Moural T, White D, Choy C, Kang C, Berkman C Int J Mol Sci. 2019; 20(13).

PMID: 31269656 PMC: 6650796. DOI: 10.3390/ijms20133247.


β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.

Fisher J, Mobashery S Cold Spring Harb Perspect Med. 2016; 6(5).

PMID: 27091943 PMC: 4852796. DOI: 10.1101/cshperspect.a025221.

References
1.
KROGH A, Larsson B, von Heijne G, Sonnhammer E . Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001; 305(3):567-80. DOI: 10.1006/jmbi.2000.4315. View

2.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View

3.
Janin Y . Antituberculosis drugs: ten years of research. Bioorg Med Chem. 2007; 15(7):2479-513. DOI: 10.1016/j.bmc.2007.01.030. View

4.
Mahapatra S, Scherman H, Brennan P, Crick D . N Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J Bacteriol. 2005; 187(7):2341-7. PMC: 1065221. DOI: 10.1128/JB.187.7.2341-2347.2005. View

5.
Bourai N, Jacobs Jr W, Narayanan S . Deletion and overexpression studies on DacB2, a putative low molecular mass penicillin binding protein from Mycobacterium tuberculosis H(37)Rv. Microb Pathog. 2011; 52(2):109-16. DOI: 10.1016/j.micpath.2011.11.003. View